INTERNATIONAL PATENT: CANGET BIOTEKPHARMA, LLC FILES APPLICATION FOR "FL118 COMPLEXES FOR TARGETING DDX5, UBE2T OR USP2A"

GENEVA, Aug. 19 -- CANGET BIOTEKPHARMA, LLC (701 Ellicott StreetB3-318Buffalo, New York 14203) filed a patent application (PCT/US2025/014017) for "FL118 COMPLEXES FOR TARGETING DDX5, UBE2T OR USP2A" on Jan 31, 2025. With publication no. WO/2025/170834, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LING, Xiang (c/o Canget BioTekpharma, LLC701 Ellicott StreetB3-318Buffalo, New York 14203), LI, Fengzhi (c/o Canget BioTekpharma, LLC701 Ellicott StreetB3-318Buffalo, New York 14203)

Abstract: A method of targeting DDX5, Ub...